Brown, K. T., Do, R., Gönen, M., Covey, A. M., Getrajdman, G. I., Sofocleous, C. T., … Abou-Alfa, G. K. (2017). Reply to A. Braillon, M. Boulin et al, and J.-H. Zhong et al. J Clin Oncol, 35(2), 258–259. https://doi.org/10.1200/JCO.2016.69.7961

Brown, Karen T., Richard Do, Mithat Gönen, Anne M. Covey, George I. Getrajdman, Constantinos T. Sofocleous, William R. Jarnagin, et al. “Reply to A. Braillon, M. Boulin et al, and J.-H. Zhong et al.” J Clin Oncol 35, no. 2 (January 10, 2017): 258–59. https://doi.org/10.1200/JCO.2016.69.7961.

Brown KT, Do R, Gönen M, Covey AM, Getrajdman GI, Sofocleous CT, et al. Reply to A. Braillon, M. Boulin et al, and J.-H. Zhong et al. J Clin Oncol. 2017 Jan 10;35(2):258–9.

Brown, Karen T., et al. “Reply to A. Braillon, M. Boulin et al, and J.-H. Zhong et al.” J Clin Oncol, vol. 35, no. 2, Jan. 2017, pp. 258–59. Pubmed, doi:10.1200/JCO.2016.69.7961.

Brown KT, Do R, Gönen M, Covey AM, Getrajdman GI, Sofocleous CT, Jarnagin WR, D’Angelica MI, Allen PJ, Erinjeri JP, Brody LA, O’Neill GP, Johnson K, Garcia AR, Beattie CM, Zhao B, Solomon SB, Schwartz LH, DeMatteo RP, Abou-Alfa GK. Reply to A. Braillon, M. Boulin et al, and J.-H. Zhong et al. J Clin Oncol. 2017 Jan 10;35(2):258–259.